EurekaMag.com logo
+ Site Statistics
References:
53,869,633
Abstracts:
29,686,251
+ Search Articles
+ Subscribe to Site Feeds
EurekaMag Most Shared ContentMost Shared
EurekaMag PDF Full Text ContentPDF Full Text
+ PDF Full Text
Request PDF Full TextRequest PDF Full Text
+ Follow Us
Follow on FacebookFollow on Facebook
Follow on TwitterFollow on Twitter
Follow on LinkedInFollow on LinkedIn

+ Translate

Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity



Iron depletion by phlebotomy with recombinant erythropoietin prior to allogeneic transplantation to prevent liver toxicity



Bone Marrow Transplantation 23(1): 95-97



Iron overload may induce liver toxicity after hematopoietic stem cell transplantation (HSCT), but it is not known if iron depletion prior to HSCT can reduce the risk of severe toxicity in this setting. We used subcutaneous recombinant erythropoietin (EPO) (25 UI/kg) three times a week and phlebotomy once a week, to prevent liver toxicity in a patient with advanced acute leukemia and liver disease due to severe iron overload, previous drug toxicity and hepatitis C viral infection. Over the 9 months prior to allogeneic HSCT, 34 phlebotomies were carried out. Serum ferritin dropped from 2964 to 239 microg/l and the ALT dropped to near normal values. At allogeneic HSCT no liver toxicity was observed, suggesting that iron depletion in the pretransplant period may contribute to reducing transplant-related toxicity in selected cases.

(PDF emailed within 0-6 h: $19.90)

Accession: 010885181

Download citation: RISBibTeXText

PMID: 10037058

DOI: 10.1038/sj.bmt.1701534



Related references

Successful treatment using iron depletion phlebotomy combined with recombinant erythropoietin after allogeneic bone marrow transplantation for myelodysplastic syndrome complicated by secondary hemochromatosis. Japanese Journal of Clinical Hematology 42(7): 571-574, 2001

Iron removal with phlebotomy and recombinant human erythropoietin in secondary hemochromatosis after allogeneic bone marrow transplantation. Pediatrics International 48(2): 174-177, 2006

Iron overload mimicking liver GVHD after allogeneic stem cell transplant Response to erythropoietin-assisted phlebotomy. Blood 102(11): 721a, November 16, 2003

Importance of iron overload and effectiveness of phlebotomy in long-term liver dysfunction after allogeneic bone marrow transplantation in non-thalassemic patients. Blood 90(10 SUPPL 1 PART 2): 385B, Nov 15, 1997

Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation. American Journal of Blood Research 2(4): 243-253, 2012

Treatment of iron overload with combination of recombinant human erythropoietin and phlebotomy. Japanese Journal of Clinical Hematology 32(7): 791-795, 1991

Human recombinant erythropoietin and phlebotomy in the treatment of iron overload in uremic patients. Changgeng Yi Xue Za Zhi 18(3): 248-253, 1995

Recombinant human erythropoietin epo and phlebotomy plb in the treatment of iron overload io in chronic hemodialysis hd patients pts. Kidney International 35(1): 253, 1989

Recombinant human erythropoietin and phlebotomy in the treatment of iron overload in chronic hemodialysis patients. American Journal of Kidney Diseases 16(2): 101-108, 1990

Recombinant human erythropoietin is effective in correcting erythropoietin-deficient anaemia after allogeneic bone marrow transplantation. British Journal of Haematology 80(4): 545-549, 1992

Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Biology of Blood and Marrow Transplantation 16(1): 115-122, 2010

Treatment of a patient with end-stage renal disease, severe iron overload and ascites by weekly phlebotomy combined with recombinant human erythropoietin. Nephron 55(2): 210-213, 1990

Prevention of graft vs host disease in allogeneic bone marrow transplantation for leukemia by t cell depletion in vitro prior to transplantation. 1985

Erythropoietin with iron supplementation to prevent allogeneic blood transfusion in total hip joint arthroplasty. Annals of Internal Medicine 133(11): 845-854, 2000

Iron burden and liver fibrosis decrease during a long-term phlebotomy program and iron chelating treatment after bone marrow transplantation. Hemoglobin 30(1): 131-137, 2006